Quintrio
Home

Stock overview

EVOGENE LTD.

EVGN

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $0.339 – $0.394
Volume 211,915
Market cap $5M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$5.3M
Price / earnings
—
Price / book
0.05×
Price / sales
0.51×
EV / sales
0.13×
EV / EBITDA
-0.08×

Profitability

Earnings per share
-$1.26
Return on assets
-15.75%
Return on equity
-16.95%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
22.2×
Quick ratio
22.2×
Cash ratio
0.87×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$13.72M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for EVGN, quarterly periods
Line itemQ1 FY2016 Mar 31, 2016Q4 FY2015 Dec 31, 2015Q3 FY2015 Sep 30, 2015Q2 FY2015 Jun 30, 2015Q1 FY2015 Mar 31, 2015Q4 FY2014 Dec 31, 2014Q3 FY2014 Sep 30, 2014Q2 FY2014 Jun 30, 2014
Revenue$2.02M$2.46M$3.31M$2.66M$2.7M$3.64M$3.16M$3.85M
Cost of revenue$1.52M$2.01M$2.49M$1.93M$1.83M$2.38M$2.34M$2.43M
Gross profit$501K$457K$822K$724K$871K$1.26M$827K$1.43M
Selling, general and administrative$998K$1.24M$1M$1.17M$963K$1.08M$984K$1.24M
Research and development$4.09M$4.58M$3.6M$4.19M$4.04M$4.78M$4.15M$3.92M
Total operating expenses$5.09M$5.83M$4.6M$5.37M$5M$5.85M$5.13M$5.15M
Operating income-$4.58M-$5.37M-$3.78M-$4.64M-$4.13M-$4.6M-$4.31M-$3.73M
Interest expense-$122K-$629K-$368K-$639K-$227K-$488K-$500K-$166K
Income before taxes-$3.37M-$5.47M-$3.38M-$4.95M-$3.41M-$4.82M-$4.18M-$3.19M
Income taxes————————
Net income-$3.37M-$5.47M-$3.38M-$4.95M-$3.41M-$4.82M-$4.18M-$3.19M
Net income attributable to common shareholders-$3.37M-$5.47M-$3.38M-$4.95M-$3.41M-$4.82M-$4.18M-$3.19M
EBITDA-$3.99M-$5.37M-$3.2M-$4.03M-$3.47M-$4.6M-$3.75M-$3.19M
Basic earnings per share-$1.30-$2.20-$1.30-$2.00-$1.30-$1.90-$1.70-$1.30
Diluted earnings per share-$1.30-$2.20-$1.30-$2.00-$1.30-$1.90-$1.70-$1.30

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Plant Genotyping Equipment Market Size to Hit 1662.43 - GlobeNewswire

The plant genotyping equipment market is experiencing significant growth due to advancements in sequencing technologies and increasing demand for high-yield, stress-tolerant crops. The market is expected to reach $1662.43 million by 2032, driven by the need for efficient, high-yield crop production methods.

Zacks Investment Research

Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates

Evogene (EVGN) delivered earnings and revenue surprises of 7.14% and 66.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jul 25, 20241-for-10reverse split
Nov 18, 20131-for-2reverse split